Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Mr. Paul Edward-Alexander HopperExecutive Chairman | 180,00k | 13,47k | Kauf | 0,07 | 12,27M | 1,49% |
| 2026-05-11 | Ms. Leslie ChongCEO, MD & Executive Director | 585,45k | 44,26k | Kauf | 0,07 - 0,08 | 3,49M | 20,16% |
| 2026-01-14 | Precision BioSciences, Inc.Unternehmen | -193,50k | 32,39k | Verkauf | 0,11 - 0,24 | 19,30M | -0,99% |
| 2026-04-16 | Ms. Leslie ChongCEO, MD & Executive Director | 65,05k | 6,76k | Kauf | 0,10 | 2,90M | 2,29% |
| 2025-12-15 | Mr. Paul Edward-Alexander HopperExecutive Chairman | 124,05k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-15 | Ms. Kimberlee Cobleigh DrapkinNon-Executive Director | 14,71k | 0,00 | Derivative Exercise and Retained Stock | - | 32,91k | 80,77% |
| 2025-12-15 | Ms. Kimberlee Cobleigh DrapkinNon-Executive Director | 29,41k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-15 | Mr. Jakob DupontNon-Executive Director | 14,71k | 0,00 | Derivative Exercise and Retained Stock | - | 32,04k | 84,85% |
| 2025-12-15 | Mr. Jakob DupontNon-Executive Director | 29,41k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-15 | Ms. Leslie ChongCEO, MD & Executive Director | 751,62k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-15 | Dr. Lesley Russell CooperIndependent Non-Executive Director | 14,71k | 0,00 | Derivative Exercise and Retained Stock | - | 624,65k | 2,41% |
| 2025-12-15 | Dr. Lesley Russell CooperIndependent Non-Executive Director | 29,41k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-21 | Mr. Paul Edward-Alexander HopperExecutive Chairman | 28,69k | 0,00 | Derivative Exercise and Retained Stock | - | 12,50M | 0,23% |
| 2025-07-21 | Ms. Leslie ChongCEO, MD & Executive Director | 170,41k | 0,00 | Derivative Exercise and Retained Stock | - | 2,84M | 6,38% |
| 2025-07-11 | Mr. Jakob DupontNon-Executive Director | 7,35k | 0,00 | Derivative Exercise and Retained Stock | - | 17,33k | 73,68% |
| 2025-07-11 | Ms. Kimberlee Cobleigh DrapkinNon-Executive Director | 7,35k | 0,00 | Derivative Exercise and Retained Stock | - | 18,21k | 67,74% |
| 2025-07-11 | Dr. Lesley Russell CooperIndependent Non-Executive Director | 7,35k | 0,00 | Derivative Exercise and Retained Stock | - | 609,95k | 1,22% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
